MIRA

MIRA Pharmaceuticals, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Aminov ErezDirector, Officer: Chief Executive Officer
$57k44.6k shares
SellNov 20, 2024
$1.27
--
Aminov ErezDirector, Officer: Chief Executive Officer
$77k55.4k shares
SellNov 19, 2024
$1.39
--
McNulty Brian Patrick10 Percent Owner
$392k200k shares
SellAug 28, 2024
$1.96
--

News

accessnewswire.comMIRA Pharmaceuticals Secures Worldwide Exclusive Rights to MIRA-55 and SKNY-1accessnewswire.comJun 4accessnewswire.comMIRA Pharmaceuticals Secures Worldwide Rights for Ketamir-2, Expanding Global IP Portfolio Across 10 Major Markets Ahead of Phase 2a in CIPNaccessnewswire.comMay 27accessnewswire.comMIRA Pharmaceuticals Reports Positive Unblinded Phase 1 Data for Ketamir-2accessnewswire.comMay 14accessnewswire.comMIRA Pharmaceuticals Announces Acceptance of Peer-Reviewed SKNY-1 Manuscript Highlighting Oral Obesity and Nicotine Addiction Drug Candidateaccessnewswire.comMay 13newsfilecorp.comVisionstate Reports 27% Q2 Revenue Growth as MIRA Platform Gains Tractionnewsfilecorp.comMay 6